Masimo Corporation (MASI)
Can Masimo (MASI) Keep the Earnings Surprise Streak Alive?
Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why Masimo (MASI) is a Great Momentum Stock to Buy
Does Masimo (MASI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Masimo Taps Katie Szyman as Permanent CEO
Szyman currently serves as the worldwide president of Advanced Patient Monitoring at Becton Dickinson and Co.
Masimo names Becton Dickinson's Katie Szyman CEO
Masimo said on Tuesday it has named Becton Dickinson executive Katie Szyman as chief executive officer after a bitter proxy battle with activist hedge fund Politan Capital Management led to the ouster of founder Joe Kiani from the medical device maker's board last year.
Masimo Stock Gains Following Solid Preliminary Q4 Revenues
MASI's revenue growth in the fourth quarter is likely to have been boosted by the continued robust adoption of its products.
Senzime Reaches Second Milestone of Masimo Collaboration with Launch of Integration to Iris Gateway
UPPSALA, SWEDEN / ACCESSWIRE / January 13, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime AB (publ.), a leader in precision-based patient monitoring, today announced that the company has reached a second milestone in its collaboration with Masimo through integration with the Masimo Iris® Gateway.
Masimo To Rally More Than 13%? Here Are 5 Top Analyst Forecasts For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
3 Medical Instruments Industry Stocks to Buy on the GenAI Wave
MASI, PEN and VCYT from the Zacks Medical Instruments industry are worth buying based on genAI adoption, strategic developments and strong fundamentals. Yet, geopolitical complications and wage and supply issues mar their prospects.
Masimo's Q3 Earnings Rise Y/Y, Healthcare Demand Drives Growth
MAMO sees a 30.7% increase in non-GAAP operating income in Q3 2024. Healthcare segment revenues increase 11.5%, driving overall growth amid strategic shifts.
MASI Stock Gains Following Q3 Earnings Beat, Gross Margin Expands
Masimo's third-quarter 2024 results continue to benefit from the strength in its Healthcare business.
Masimo Corporation (MASI) Q3 2024 Earnings Call Transcript
Masimo Corporation (NASDAQ:MASI ) Q3 2024 Earnings Conference Call November 5, 2024 4:30 PM ET Company Participants Eli Kammerman - VP of Business Development and IR Michelle Brennan - Interim CEO Micah Young - EVP and CFO Bilal Muhsin - COO Conference Call Participants Jason Bednar - Piper Sandler Marie Thibault - BTIG Michael Polark - Wolfe Research Frederick Wise - Stifel Matt Taylor - Jefferies Vik Chopra - Wells Fargo Michael Matson - Needham Jayson Bedford - Raymond James Operator Ladies and gentlemen, good afternoon, and welcome to Masimo's Third Quarter 2024 Earnings Conference Call. The company's press release is available at www.masimo.com.
Masimo (MASI) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Masimo (MASI) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
